The ENLIGHTEN 2 trial also met the key secondary endpoints of 3CS at 24 weeks in the full population (i.e., patients with and without nasal polyps) (-0.90; p=0.0209) and in the clinically-validated ...

Q2 2025 Earnings Call Transcript August 12, 2025 ADC Therapeutics S.A. misses on earnings expectations. Reported EPS is $-0.5 ...

With government funding progress halted and a government shutdown deadline looming, President Donald Trump is reaching across ...

Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphomaInitiated the PiNACL ...

Detailed price information for Cg Oncology Inc (CGON-Q) from The Globe and Mail including charting and trades.

Q2 2025 Earnings Call Transcript August 13, 2025 StandardAero, Inc. misses on earnings expectations. Reported EPS is $0.2 EPS, expectations were $0.21. Operator: Greetings, and welcome to the ...

During a live event, Nathan Denlinger, DO, MS, discussed outcomes of the ZUMA-7 trial in diffuse large B-cell lymphoma.

Revenue of $34.1 Million, up 520% Closed 46 Transactions in Q2 with Total Raise Amount of More Than $288.9 Million between both our Private & Public Transactions ...

Find all the latest updates related to the FY26 Q1 results of Indian Oil Corporation, Ashok Leyland, Vodafone Idea, Patanjali Foods, Glenmark Pharma, IRB Infrastructure Developers, Inox Wind, ...

Mipletamig's 85% frontline AML remission rate and favorable safety profile drive APVO's differentiated CD3 portfolio expansion with APVO455, a Nectin-4 x CD3 bispecific for multiple solid tumor ...

National Taxpayer Advocate Erin Collins wrote Tuesday in her blog that the IRS reminder of the language in the Internal ...

NerdWallet's list of the best savings accounts feature options with great customer service, higher-than-average interest rates and low or no fees.